BCWORLD PHARM Net Income vs. Cash And Equivalents
| 200780 Stock | KRW 4,800 10.00 0.21% |
For BCWORLD PHARM profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BCWORLD PHARM to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BCWORLD PHARM Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BCWORLD PHARM's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BCWORLD PHARM Co over time as well as its relative position and ranking within its peers.
BCWORLD |
BCWORLD PHARM Cash And Equivalents vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BCWORLD PHARM's current stock value. Our valuation model uses many indicators to compare BCWORLD PHARM value to that of its competitors to determine the firm's financial worth. BCWORLD PHARM Co is number one stock in net income category among its peers. It also is number one stock in cash and equivalents category among its peers creating about 0.91 of Cash And Equivalents per Net Income. The ratio of Net Income to Cash And Equivalents for BCWORLD PHARM Co is roughly 1.10 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BCWORLD PHARM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BCWORLD PHARM's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BCWORLD Cash And Equivalents vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
BCWORLD PHARM |
| = | 3.02 B |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
BCWORLD PHARM |
| = | 2.75 B |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
BCWORLD Cash And Equivalents Comparison
BCWORLD PHARM is currently under evaluation in cash and equivalents category among its peers.
BCWORLD Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BCWORLD PHARM. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BCWORLD PHARM position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BCWORLD PHARM's important profitability drivers and their relationship over time.
Use BCWORLD PHARM in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BCWORLD PHARM position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCWORLD PHARM will appreciate offsetting losses from the drop in the long position's value.BCWORLD PHARM Pair Trading
BCWORLD PHARM Co Pair Trading Analysis
The ability to find closely correlated positions to BCWORLD PHARM could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BCWORLD PHARM when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BCWORLD PHARM - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BCWORLD PHARM Co to buy it.
The correlation of BCWORLD PHARM is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BCWORLD PHARM moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BCWORLD PHARM moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BCWORLD PHARM can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BCWORLD PHARM position
In addition to having BCWORLD PHARM in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Measuring and Control Equipment Thematic Idea Now
Measuring and Control Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Measuring and Control Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Measuring and Control Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BCWORLD Stock
To fully project BCWORLD PHARM's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BCWORLD PHARM at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BCWORLD PHARM's income statement, its balance sheet, and the statement of cash flows.